ADHD Rates Surge Among American Children
ADHD cases have risen at an alarming rate in the United States according to new data from the U.S. Centers for Disease Control and Prevention (CDC). As of 2022, one in nine children had been diagnosed with ADHD—an increase of 5.4 million diagnoses since 2016.1 2 ADHD is formally known as attention-deficit/hyperactivity disorder. Researchers analyzed […]
Pharma Influences Diagnoses and Treatments in “Bible” of Psychiatric Disorders
A new study published in the British Medical Journal (BMJ) found that 55 of the 92 American doctors who determine what diagnoses and treatments are included in the American Psychiatric Association’s (APA) most recent edition of their Diagnostic and Statistical Manual (DSM) collectively received more than $14 million in previously undisclosed industry funding.1 The APA’s […]
Big Pharma’s Revolving Door With Government Health Agencies
More than half of the staff at the U.S. Centers for Disease Control and Prevention (CDC) go to work for pharmaceutical giants when they leave the government, according to a new report by researchers at the University of Southern California and Harvard University. The report showed that eight percent of the CDC staff came from […]
Big Pharma’s Influence on U.S. Medical Schools is Significant
An informal survey of medical schools conducted in 2005 by National Public Radio (NPR) showed that a number of universities and academic institutions are funded by pharmaceutical giants and other health industry sources. The survey, carried out through telephone calls and internet searches, found that two to six percent of the yearly budget of medical […]
Medical Journals are Funded by the Pharmaceutical Industry
The medical community has long used scientific research to guide individual care, industry protocols, and what is known within the medical community as best practice or standard of care. With differing opinions about best treatment options, the final say often comes down to what clinical research shows—with documentation in peer-reviewed medical journals being the gold […]
Why are Standards So Lax on COVID Drug Approvals?
Many scientists made a career fighting for better regulatory standards. Strangely, when it comes to the regulatory policy around COVID-19, they are dead quiet. First, consider that EUA ( emergency use authorization) is like accelerated approval. Both require lower levels of evidence, and are predicated on the fact that we’re dealing with a situation that […]
